Andréas Hartmann
YOU?
Author Swipe
View article: Author Correction: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
Author Correction: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis Open
View article: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis
Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis Open
View article: The diagnostic and therapeutic journey of Tourette syndrome: Thematic analysis of the difficulties experienced by parents of patients
The diagnostic and therapeutic journey of Tourette syndrome: Thematic analysis of the difficulties experienced by parents of patients Open
Our study sheds light on how the parents of children with TS experience the diagnostic and therapeutic journey. By highlighting recurrent themes experienced by families, we hope that the results will be beneficial to both parents and child…
View article: Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease Open
Background The EARLYSTIM trial demonstrated for Parkinson's disease patients with early motor complications that deep brain stimulation of the subthalamic nucleus (STN‐DBS) and best medical treatment (BMT) was superior to BMT alone. Object…
View article: How does Tourette syndrome impact adolescents’ daily living? A text mining study
How does Tourette syndrome impact adolescents’ daily living? A text mining study Open
View article: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life Open
Background Subthalamic nucleus deep brain stimulation (STN‐DBS) effectively treats motor symptoms and quality of life (QoL) of advanced and fluctuating early Parkinson's disease. Little is known about the relation between electrode positio…
View article: Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery
Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery Open
This study provides Class II evidence that in patients with PD eligible for STN-DBS, the presence of probable RBD preoperatively is not associated with poorer outcomes 1 year post surgery.
View article: Faculty Opinions recommendation of Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion.
Faculty Opinions recommendation of Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion. Open
Ataxia, causing imbalance, dizziness and falls, is a leading cause of neurological disability.We have recently identified a biallelic intronic AAGGG repeat expansion in replication factor complex subunit 1 (RFC1) as the cause of cerebellar…
View article: Author Index
Author Index Open
View article: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease Open
NCT00354133.
View article: Longitudinal analysis of impulse control disorders in Parkinson disease
Longitudinal analysis of impulse control disorders in Parkinson disease Open
NCT01564992.
View article: Disentangling Tourette syndrome heterogeneity through hierarchical ascendant clustering
Disentangling Tourette syndrome heterogeneity through hierarchical ascendant clustering Open
Aim To explore the heterogeneity of Tourette syndrome as part of a neurodevelopmental spectrum. Method Using hierarchical ascendant clustering based on tic symptoms, developmental milestones, and neurodevelopmental comorbidities, we analyz…
View article: Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome
Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome Open
View article: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts Open
View article: Correction: Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial
Correction: Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial Open
[This corrects the article DOI: 10.1371/journal.pone.0158235.].
View article: Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome
Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome Open
The dopamine partial agonist aripiprazole is increasingly used to treat pathologies for which other antipsychotics are indicated because it displays fewer side effects, such as sedation and depression-like symptoms, than other dopamine rec…
View article: Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial
Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial Open
ClinicalTrials.gov NCT01341431.
View article: Referee report. For: Provisional Tic Disorder: What to tell parents when their child first starts ticcing [version 1; referees: 1 approved]
Referee report. For: Provisional Tic Disorder: What to tell parents when their child first starts ticcing [version 1; referees: 1 approved] Open
View article: Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease
Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease Open